Darragh McArt

Medicine & Life Sciences

1. Adenocarcinoma 10%
2. Adjuvant Chemotherapy 21%
3. asparaginylendopeptidase 9%
4. Atlases 9%
5. Biomarkers 47%
6. Biomedical Research 8%
7. Biopsy 10%
8. Breast Neoplasms 39%
9. Caspase 8 16%
10. cathepsin S 8%
11. Chemoradiotherapy 9%
12. Colonic Neoplasms 17%
13. Colorectal Neoplasms 100%
14. Comet Assay 16%
15. Cystatin M 11%
16. DNA Damage 9%
17. Drug Therapy 11%
18. Fluorouracil 8%
19. Gene Expression 28%
20. Genes 24%
21. GTP Phosphohydrolases 13%
22. High-Throughput Nucleotide Sequencing 10%
23. human ERBB2 protein 14%
24. Immunohistochemistry 22%
25. Molecular Pathology 15%
26. Mutation 14%
27. Neoplasm Genes 15%
28. Neoplasms 54%
29. Non-Small Cell Lung Carcinoma 10%
30. Northern Ireland 11%
31. Ovarian Neoplasms 10%
32. Pathology 14%
33. Precision Medicine 8%
34. Prostatic Neoplasms 13%
35. Receptor Protein-Tyrosine Kinases 10%
36. Rectal Neoplasms 12%
37. Recurrence 8%
38. RNA Sequence Analysis 10%
39. RNA-Seq 14%
40. Software 13%
41. Survival 23%
42. Technology 8%
43. Therapeutics 20%
44. TNF-Related Apoptosis-Inducing Ligand Receptors 10%
45. Transcriptome 11%
46. Triple Negative Breast Neoplasms 9%
47. Tumor Biomarkers 11%